Deuterium-depleted water research explores whether changing the hydrogen-isotope environment can influence cellular metabolism, redox balance, proliferation, apoptosis and tumor behavior.
Share your diagnosis, current treatment and the questions you want the clinical team to consider.
Tell us what you are facing and what you hope to understand. The team will follow up personally.
Sunridge reviews deuterium-depleted water as one part of a broader metabolic and integrative strategy. This page organizes the published research by cancer type and biological finding.
Deuterium-depleted water reduced proliferation, tumorsphere formation, migration, invasion and stemness markers through ROS/FoxM1-associated signaling.
A clinical report evaluated deuterium depletion with conventional treatment and reported an improvement in median survival in glioblastoma patients.
DDW inhibited A549 proliferation, induced apoptotic changes and reduced H460 tumor weight by approximately 30% in the reported model.
Proteomic research connected DDW with mitochondrial redox disruption, slower growth and apoptosis-associated stress responses in A549 cells.
A review summarizes deuterium-depletion findings across cellular metabolism, cancer-cell growth and additional biological systems.
An in-vitro assessment evaluated breast, stomach, colon, prostate and glioblastoma cell lines and reported antineoplastic effects from deuterium depletion.
A retrospective series followed 204 previously treated patients in remission and reported a low cancer-related death count and a large non-relapse group during follow-up.
A systematic review of 15 studies concluded that DDW alone or with chemotherapy inhibited cancer progression in most included experiments.
DDW inhibited proliferation and migration in nasopharyngeal-carcinoma cell research involving NQO1-associated biology.
An overview reported slower multiplication in several cancer cell lines and regression signals in breast and prostate xenograft research.
Our Patient Care Team can help you begin a conversation about your diagnosis, current oncology plan, goals, medicines and integrative options used at Sunridge.
14200 N Northsight Blvd #160
Scottsdale, Arizona 85260
Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM
Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.
This introductory call is not a medical consultation and does not establish a physician-patient relationship.
